Flash ReportWalgreens to Acquire Rite Aid in $17.2 Billion Deal Coresight Research October 28, 2015 Executive Summary Tuesday, Oct. 27, after the market close, Walgreens Boots Alliance announced an agreement to acquire smaller drugstore chain Rite Aid for $9.4 billion in cash, offering $9 per share in cash, which represents a 48% premium to Rite Aid’s closing price of $6.08 on Monday.Including debt, the deal is valued at $17.2 billion, the company said. The deal would bring together the #1 and #3 retail pharmacy companies, creating a pharmacy giant with over 13,000 stores and more than $67.1 billion in combined revenue, according toDrug Store News’s Annual PoweRx Industry Rankings. The combined company would have an especially strong presence in California and New York. The combination is expected to realizecost synergies of at least $1 billion annually. The boards of both companies have approved the transaction, which must receive Hart-‐Scott-‐Rodino approval and is expected to close during the second half of calendar 2016. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: Middle-Income Consumers Drive Improved Financial Optimism: US Consumer Survey InsightsAI Playbook: Content & Cocktails at NRF 2026 Event—Moving Forward in Deploying AIWeekly US and UK Store Openings and Closures Tracker 2025, Week 9: Joann To Close an Additional 300+ Stores, Shuttering All LocationsAnalyst Corner: Decoding the Resurgence of Online Grocery Retail in the US, with Sujeet Naik